GWM
BSX icon

GDS Wealth Management’s Boston Scientific BSX Stock Holding History

GDS Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-135,991
Closed -$8.53M – 233
2026
Q1 		$8.53M Buy
135,991
+6,640
+5% +$531K 0.51% 66
2025
Q4 		$12.3M Buy
129,351
+7,274
+6% +$713K 0.77% 53
2025
Q3 		$11.9M Buy
122,077
+9,428
+8% +$976K 0.79% 55
2025
Q2 		$12.1M Buy
112,649
+40,528
+56% +$4.1M 0.88% 48
2025
Q1 		$7.28M Buy
72,121
+50,525
+234% +$5.09M 0.62% 51
2024
Q4 		$1.93M Buy
21,596
+15,747
+269% +$1.39M 0.18% 79
2024
Q3 		$490K Buy
+5,849
New +$461K 0.05% 100

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GDS Wealth Management's BSX Position: Q2 2026 in Review

GDS Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 135,991 shares — an estimated $8.53M sold.

GDS Wealth Management first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $12.3M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • GDS Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • GDS Wealth Management sold 135,991 Boston Scientific shares in Q2 2026, an estimated $8.53M.
  • GDS Wealth Management first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • GDS Wealth Management's Boston Scientific position peaked at $12.3M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GDS Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.